Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

616
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
616
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

519
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
519
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

36.3K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
36.3K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haemodynamic effects of ketamine in the paediatric cardiac intensive care unit: insights from high-fidelity physiologic data.

Cardiology in the young·2026
Same author

Long-term results of thumb carpometacarpal joint arthrodesis.

Archives of orthopaedic and trauma surgery·2026
Same author

Factors associated with variation in treatment of the distal radioulnar joint after plate fixation of distal radial fractures.

The Journal of hand surgery, European volume·2026
Same author

Successful thrombectomy for acute ischaemic stroke in an infant supported with a single ventricle assist device.

Cardiology in the young·2026
Same author

Restoration of CPAK type in total knee arthroplasty does not lead to superior clinical outcome: A study based on arthroplasty registry data.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2026
Same author

Combined trochleoplasty and medial patellofemoral ligament reconstruction reduces patellar height.

Journal of experimental orthopaedics·2026

Related Experiment Videos

Fibrates: where are we now?

Rohit Seth Loomba1, Rohit Arora

  • 1VA Medical Center, North Chicago, Illinois, USA.

Therapeutic Advances in Cardiovascular Disease
|January 16, 2009
PubMed
Summary
This summary is machine-generated.

Fibrate and statin combination therapy effectively manages dyslipidemia, improving lipid levels without significant side effects when gemfibrozil is excluded. This approach is superior to monotherapy for cardiovascular disease risk reduction.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Cardiovascular disease is a leading global cause of mortality.
  • Dyslipidemia significantly increases cardiovascular disease risk.
  • Effective dyslipidemia management is crucial for cardiovascular disease prevention.

Purpose of the Study:

  • To review dyslipidemia treatment using fibrate therapy.
  • To contrast fibrate therapy with statin therapy and combination therapy.
  • To evaluate the efficacy and safety of different lipid-lowering strategies.

Main Methods:

  • Systematic review of studies identified through Medline and Cochrane Library.
  • Focus on studies discussing fibrates, statins, and combined therapy.
  • Quality assessment of selected studies based on methodology, results, and data.

Main Results:

  • Combination fibrate and statin therapy can be more effective than monotherapy in achieving optimal lipid levels.
  • Combined therapy demonstrated effectiveness without significant side effects, provided gemfibrozil is not used.
  • Quality assessment confirmed the scientific evidence supporting these findings.

Conclusions:

  • Combination therapy, excluding gemfibrozil, offers superior lipid management for cardiovascular disease risk.
  • Fibrates play a key role in targeting specific lipid abnormalities.
  • Further research supports optimized combination therapies for dyslipidemia.